Position in BMY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$152,170,850
+$41,108,390 QoQ
Shares Held
2,509,000
+21.9% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Employees Provident Fund Board holds $1,134,862,339 across 8 Drug Manufacturers - General names. BMY ranks #3 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
524,361 | $482,291,516 | |
| 2 | MRK |
Merck & Co., Inc.
|
1,895,165 | $227,969,397 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
2,509,000 | $152,170,850 | |
| 4 | BIIB |
Biogen Inc.
|
704,196 | $129,100,252 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
346,000 | $48,222,020 | |
| 6 | JNJ |
Johnson & Johnson
|
182,381 | $44,581,211 | |
| 7 | ABBV |
AbbVie Inc.
|
145,134 | $31,565,193 | |
| 8 | AMGN |
Amgen Inc
|
53,892 | $18,961,900 |
All Filings in BMY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $152,170,850 | 2,509,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $111,062,460 | 2,059,000 | Shares | Sole | 2026-03-03 | |
| 2025-09-30 | $89,207,800 | 1,978,000 | Shares | Sole | 2026-03-17 | |
| 2025-06-30 | $91,561,620 | 1,978,000 | Shares | Sole | 2026-03-17 | |
| 2025-03-31 | $111,359,201 | 1,825,860 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $162,134,104 | 2,866,586 | Shares | Sole | 2026-03-17 | |
| 2024-09-30 | $148,658,643 | 2,873,186 | Shares | Sole | 2026-03-17 | |
| 2024-06-30 | $102,595,172 | 2,470,387 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $129,092,562 | 2,380,464 | Shares | Sole | 2026-03-18 | |
| 2023-12-31 | $89,686,493 | 1,747,934 | Shares | Sole | 2026-03-18 | |
| 2023-09-30 | $99,104,344 | 1,707,518 | Shares | Sole | 2026-03-18 | |
| 2023-06-30 | $33,976,379 | 531,296 | Shares | Sole | 2026-03-31 | |
| 2023-03-31 | $7,998,997 | 115,409 | Shares | Sole | 2026-03-18 | |
| 2022-06-30 | $55,776,567 | 724,371 | Shares | Sole | 2026-03-18 | |
| 2022-03-31 | $61,066,152 | 836,179 | Shares | Sole | 2026-03-18 | |
| 2021-12-31 | $59,473,545 | 953,866 | Shares | Sole | 2026-03-18 | |
| 2021-09-30 | $52,376,751 | 885,191 | Shares | Sole | 2026-03-18 | |
| 2021-06-30 | $59,148,462 | 885,191 | Shares | Sole | 2026-03-18 | |
| 2021-03-31 | $55,882,107 | 885,191 | Shares | Sole | 2026-03-18 | |
| 2020-12-31 | $54,908,397 | 885,191 | Shares | Sole | 2026-03-18 | |
| 2020-09-30 | $40,662,108 | 674,442 | Shares | Sole | 2026-03-20 | |
| 2020-06-30 | $27,302,721 | 464,332 | Shares | Sole | 2026-03-31 | |
| 2020-03-31 | $20,701,780 | 371,399 | Shares | Sole | 2026-03-20 | |
| No filing history on record for this holder in this stock. | ||||||